Stay updated on IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial page.

Latest updates to the IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check30 days agoNo Change Detected
- Check38 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference5%
- Check45 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check59 days agoChange DetectedThe website has posted new results (Revision: v2.14.1) on January 17, 2025, following the deletion of the previous results submitted (Revision: v2.14.0) on July 19, 2024.SummaryDifference2%
- Check66 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.SummaryDifference0.9%
- Check95 days agoChange DetectedThe website has updated to version v2.13.3, adding 'Results Submitted' while removing 'No Results Posted' from the previous version v2.13.2.SummaryDifference0.8%
Stay in the know with updates to IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial page.